Tc99m-MDP uptake in ascitic fluid in a patient with prostate carcinoma: A clue to detect metastases

Bone scintigraphy with Tc-99m methylene diphosphonate (MDP) is used to detect metastases in patients with cancer. Uptake in non-osseous, non-urologic tissues is occasionally found in the routine bone scintigraphy, which may mimic as metastatic lesions. The authors describe the case of a 70-year-old...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Dhritiman, Manohar, Kuruva, Kamleshwaran, Koramadai Karuppuswamy, Bhattacharya, Anish, Singh, Baljinder, Mittal, Bhagwant Rai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543586/
https://www.ncbi.nlm.nih.gov/pubmed/23326072
http://dx.doi.org/10.4103/0972-3919.104003
Descripción
Sumario:Bone scintigraphy with Tc-99m methylene diphosphonate (MDP) is used to detect metastases in patients with cancer. Uptake in non-osseous, non-urologic tissues is occasionally found in the routine bone scintigraphy, which may mimic as metastatic lesions. The authors describe the case of a 70-year-old man with prostate cancer, showing diffuse tracer uptake in the left hemithorax and entire abdomen on bone scan that required additional imaging modality for localization. Careful interpretation is needed of the unusual uptake of radiotracer in regions other than the skeleton for metastatic work up.

Ejemplares similares